IntroductionA cluster randomized trial (CRT) in Bangladesh found that Vi-tetanus toxoid (Vi-TT) vaccine conferred 85% protection to vaccinees at 18 months of follow-up; however, it failed to confer significant herd protection to non-vaccinees.
MethodsIn the CRT, children aged 9 months to <16 years from 150 clusters received one dose of either Vi-TT or Japanese encephalitis vaccine. To evaluate whether herd protection was evident, we analyzed two years of follow-up data by quartiles of clusters with ascending levels of Vi-TT coverage.
Ahmmed, F. et al. · CC-BY 4.0